GO Term | Evidence Code | PMID |
---|---|---|
phosphatidylinositol biosynthetic process |
|
|
macroautophagy |
|
GO Term | Evidence Code | PMID |
---|---|---|
phosphatidylinositol-3-phosphate phosphatase activity | ||
protein serine/threonine phosphatase activity |
|
|
phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity |
|
|
protein binding |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:3571 | liver cancer | |
DOID:0050588 | muscular dystrophy-dystroglycanopathy type B1 | |
DOID:0050700 | cardiomyopathy | |
DOID:0060260 | ptosis | |
DOID:0060261 | congenital ptosis | |
DOID:0080089 | tubular aggregate myopathy 1 | |
DOID:0080102 | congenital myopathy 4A | |
DOID:0110632 | megaconial type congenital muscular dystrophy | |
DOID:0110633 | rigid spine muscular dystrophy 1 | |
DOID:0110634 | congenital muscular dystrophy 1B |
HPO ID | HPO Term |
---|---|
HP:0003712 | Skeletal muscle hypertrophy |
HP:0003738 | Exercise-induced myalgia |
HP:0003803 | Type 1 muscle fiber predominance |
HP:0004488 | Macrocephaly at birth |
HP:0005268 | Miscarriage |
HP:0005335 | Sleepy facial expression |
HP:0007126 | Proximal amyotrophy |
HP:0008180 | Mildly elevated creatine kinase |
HP:0008948 | Proximal upper limb amyotrophy |
HP:0008981 | Calf muscle hypertrophy |
Disease ID | Disease Name |
---|---|
ORPHA:169189 |
|
OMIM:160150 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
108534803 | RHIBE41425 | ||
104667167 | RHIRO37384 | ||
100594364 | NOMLE19868 | ||
113151701 | ANATE35187 | ||
107569464 | SINGR78731 | ||
107586366 | SINGR37568 | ||
111584396 | AMPOC26082 | ||
109514829 | HIPCM25683 | ||
105299058 | PTEVA02718 | ||
115043061 | ECHNA05205 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024